Dino C. Miano
InvestorSenior Vice President, CMC and Technical Operations at Avalo Therapeutics
Baltimore, Maryland, United States
About
Over 25 years of pharmaceutical development experience in analytical chemistry and product development. Previously Executive Director at Alexion leading analytical and pharmaceutical development groups supporting development and commercialization of multiple rare disease therapies including Soliris, Strensiq, Kanuma, and Ultomiris.
Experience
- Avalo TherapeuticsVP CMC Biologicscurrent2021 — presentWayne, Pennsylvania, United States
- Alexion PharmaceuticalsExecutive Director, Global Analytical and Pharmaceutical Development2015 — 2021Alexion Pharmaceuticals, New Haven, CT
- Alexion PharmaceuticalsSenior Director, Analytical & Pharmaceutical Development2014 — 2015Cheshire, Connecticut, United States
- Alexion PharmaceuticalsDirector, Analytical Sciences2008 — 2014Cheshire, Connecticut, United States
- Alexion PharmaceuticalsAssociate Director, Analytical Sciences2003 — 2008Cheshire, Connecticut, United States
- Alexion PharmaceuticalsManager, Quality Control1999 — 2003New Haven, Connecticut, United States
- Alexion PharmaceuticalsSenior Scientist1998 — 1999New Haven, Connecticut, United States
- R.W. Johnson Pharmaceutical InstituteScientist, Analytical Development1997 — 1998Raritan, New Jersey, United States
- R.W. Johnson Pharmaceutical Research InstitutePost Doc, Protein Development1995 — 1997Raritan, New Jersey, United States
Skills & more
FDA9Drug Discovery4Change Control4Western Blotting2Biotechnology16GMP5ELISA2Protein Chemistry9Biopharmaceuticals14Sop4Validation7Clinical Development3
+10 more
Protein PurificationSDS-PAGELifesciencesGLPLife SciencesTechnology TransferGood Laboratory Practice (GLP)SOPPharmaceutical IndustryLIMSFrom Dino's professional profile.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Managing Partner at Scion Life Sciences
Aaron Kantoff
Board Member at Avalo Therapeutics
Amy Conrad
Senior Events Manager at Volta Labs
Amy Conrad
Director of Events & Community Engagement at Volta
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Garrett Lauderdale
Vice President at Idea of La Crosse
Frequently asked questions
- Who is Dino C. Miano?
- Over 25 years of pharmaceutical development experience in analytical chemistry and product development. Previously Executive Director at Alexion leading analytical and pharmaceutical development groups supporting development and commercialization of multiple rare disease therapies including Soliris, Strensiq, Kanuma, and Ultomiris.
- Where does Dino C. Miano work?
- Dino C. Miano is Senior Vice President, CMC and Technical Operations at Avalo Therapeutics.
- Where did Dino C. Miano go to school?
- Dino C. Miano studied at University of Massachusetts (Ph. D., Biochemistry).
Shared employers
Also worked at Alexion Pharmaceuticals9
Abbie CelnikerInvestor at Third Rock VenturesSeung Hyun Moon, MD, MPAVenture Partner at Adelphi Ventures Management, LlcRomesh SubramanianVenture Partner at Scion Life SciencesChristina BroomesCommercial Advisor at 2Flo VenturesJohn ReyndersChief Data Scientist & Venture Partner at Iaso VenturesMichihiko WadaChief Regulatory and Development Officer at Newton Biocapital
+ 3 more